It has also been shown that reducing TAOK expression enhances the sensitivity to γ-radiation in colony survival assays [13], and knockdown of TAOK3 abolishes the drug resistance to microtubule-targeted drugs in breast cancer cells [53]. The gene discussed is TAOK3; the disease is breast carcinoma.